{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:59:59Z","timestamp":1792184399991,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100012697","name":"Clifford Craig Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s41030-026-00367-w","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:31:30Z","timestamp":1779283890000},"page":"637-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Peripheral Blood Inflammatory Markers and Immune Cell Profiles in Smokers With and Without COPD"],"prefix":"10.1007","volume":"12","author":[{"given":"Wenying","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddison","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josie","family":"Larby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapha","family":"Shibeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Bozinovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Selemidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"McQualter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Vlahos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhwinder Singh","family":"Sohal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"367_CR1","unstructured":"Global strategy for prevention, diagnosis and management of COPD: 2023 Report. Fontana: global initiative for chronic obstructive lung disease. 2023."},{"issue":"13","key":"367_CR2","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMra1900475","volume":"381","author":"A Agust\u00ed","year":"2019","unstructured":"Agust\u00ed A, Hogg JC. Update on the pathogenesis of chronic obstructive pulmonary disease. N Engl J Med. 2019;381(13):1248\u201356.","journal-title":"N Engl J Med"},{"issue":"1","key":"367_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12931-024-02961-5","volume":"25","author":"W Lu","year":"2024","unstructured":"Lu W, Aarsand R, Schotte K, et al. Tobacco and COPD: presenting the world health organization (WHO) tobacco knowledge summary. Respir Res. 2024;25(1):338.","journal-title":"Respir Res"},{"issue":"4","key":"367_CR4","doi-asserted-by":"publisher","first-page":"L585","DOI":"10.1152\/ajplung.00160.2020","volume":"319","author":"KD McAlinden","year":"2020","unstructured":"McAlinden KD, Eapen MS, Lu W, Sharma P, Sohal SS. The rise of electronic nicotine delivery systems and the emergence of electronic-cigarette-driven disease. Am J Physiol Lung Cell Mol Physiol. 2020;319(4):L585\u201395.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"367_CR5","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00159-2018","author":"SS Sohal","year":"2019","unstructured":"Sohal SS, Eapen MS, Naidu VGM, Sharma P. IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette. ERJ Open Res. 2019. https:\/\/doi.org\/10.1183\/23120541.00159-2018.","journal-title":"ERJ Open Res"},{"issue":"1","key":"367_CR6","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.1038\/s41467-023-42913-z","volume":"14","author":"G Liu","year":"2023","unstructured":"Liu G, Haw TJ, Starkey MR, et al. TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase. Nat Commun. 2023;14(1):7349.","journal-title":"Nat Commun"},{"key":"367_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1404615","volume":"15","author":"J Xu","year":"2024","unstructured":"Xu J, Zeng Q, Li S, Su Q, Fan H. Inflammation mechanism and research progress of COPD. Front Immunol. 2024;15:1404615.","journal-title":"Front Immunol"},{"key":"367_CR8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00651-2019","author":"C Brightling","year":"2019","unstructured":"Brightling C, Greening N. Airway inflammation in COPD: progress to precision medicine. Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.00651-2019.","journal-title":"Eur Respir J"},{"issue":"1","key":"367_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","volume":"138","author":"PJ Barnes","year":"2016","unstructured":"Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16\u201327.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"367_CR10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/all.13760","volume":"74","author":"PJ Barnes","year":"2019","unstructured":"Barnes PJ. Inflammatory endotypes in COPD. Allergy. 2019;74(7):1249\u201356.","journal-title":"Allergy"},{"key":"367_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.pathol.4.110807.092145","volume":"4","author":"JC Hogg","year":"2009","unstructured":"Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol. 2009;4:435\u201359.","journal-title":"Annu Rev Pathol"},{"issue":"10","key":"367_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/17476348.2017.1360769","volume":"11","author":"MS Eapen","year":"2017","unstructured":"Eapen MS, Myers S, Walters EH, Sohal SS. Airway inflammation in chronic obstructive pulmonary disease (COPD): a true paradox. Expert Rev Respir Med. 2017;11(10):827\u201339.","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"367_CR13","doi-asserted-by":"publisher","first-page":"13392","DOI":"10.1038\/s41598-017-13888-x","volume":"7","author":"MS Eapen","year":"2017","unstructured":"Eapen MS, Hansbro PM, McAlinden K, et al. Abnormal M1\/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD). Sci Rep. 2017;7(1):13392.","journal-title":"Sci Rep"},{"issue":"6","key":"367_CR14","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/resp.13021","volume":"22","author":"MS Eapen","year":"2017","unstructured":"Eapen MS, McAlinden K, Tan D, et al. Profiling cellular and inflammatory changes in the airway wall of mild to moderate COPD. Respirology. 2017;22(6):1125\u201332.","journal-title":"Respirology"},{"key":"367_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081949","author":"A Mulvanny","year":"2022","unstructured":"Mulvanny A, Pattwell C, Beech A, Southworth T, Singh D. Validation of sputum biomarker immunoassays and cytokine expression profiles in COPD. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10081949.","journal-title":"Biomedicines"},{"issue":"4","key":"367_CR16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/0091-6749(93)90078-T","volume":"92","author":"JY Lacoste","year":"1993","unstructured":"Lacoste JY, Bousquet J, Chanez P, et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 1993;92(4):537\u201348.","journal-title":"J Allergy Clin Immunol"},{"issue":"26","key":"367_CR17","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1056\/NEJMoa032158","volume":"350","author":"JC Hogg","year":"2004","unstructured":"Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645\u201353.","journal-title":"N Engl J Med"},{"issue":"1","key":"367_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/thorax.55.1.12","volume":"55","author":"SR Rutgers","year":"2000","unstructured":"Rutgers SR, Postma DS, ten Hacken NHT, et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax. 2000;55(1):12\u20138.","journal-title":"Thorax"},{"issue":"6","key":"367_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1165\/rcmb.2009-0220TR","volume":"41","author":"PJ Barnes","year":"2009","unstructured":"Barnes PJ. The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2009;41(6):631\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"23","key":"367_CR20","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1056\/NEJMra0804752","volume":"360","author":"MG Cosio","year":"2009","unstructured":"Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med. 2009;360(23):2445\u201354.","journal-title":"N Engl J Med"},{"issue":"1","key":"367_CR21","doi-asserted-by":"publisher","first-page":"11700","DOI":"10.1038\/s41598-020-68670-3","volume":"10","author":"SW Moon","year":"2020","unstructured":"Moon SW, Leem AY, Kim YS, et al. Low serum lymphocyte level is associated with poor exercise capacity and quality of life in chronic obstructive pulmonary disease. Sci Rep. 2020;10(1):11700.","journal-title":"Sci Rep"},{"issue":"6","key":"367_CR22","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1440-1843.2010.01808.x","volume":"15","author":"SS Sohal","year":"2010","unstructured":"Sohal SS, Reid D, Soltani A, et al. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology. 2010;15(6):930\u20138.","journal-title":"Respirology"},{"issue":"1","key":"367_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1465-9921-14-120","volume":"14","author":"SS Sohal","year":"2013","unstructured":"Sohal SS, Walters EH. Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD). Respir Res. 2013;14(1):120.","journal-title":"Respir Res"},{"key":"367_CR24","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00876-2020","author":"MS Eapen","year":"2021","unstructured":"Eapen MS, Lu W, Hackett TL, et al. Increased myofibroblasts in the small airways, and relationship to remodelling and functional changes in smokers and COPD patients: potential role of epithelial-mesenchymal transition. ERJ Open Res. 2021. https:\/\/doi.org\/10.1183\/23120541.00876-2020.","journal-title":"ERJ Open Res"},{"key":"367_CR25","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00581-2023","author":"W Lu","year":"2023","unstructured":"Lu W, Eapen MS, Hardikar A, et al. Epithelial-mesenchymal transition changes in nonsmall cell lung cancer patients with early COPD. ERJ Open Res. 2023. https:\/\/doi.org\/10.1183\/23120541.00581-2023.","journal-title":"ERJ Open Res"},{"issue":"11","key":"367_CR26","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ebiom.2015.10.016","volume":"2","author":"SS Sohal","year":"2015","unstructured":"Sohal SS. Chronic obstructive pulmonary disease (COPD) and lung cancer: epithelial mesenchymal transition (EMT), the missing link? EBioMedicine. 2015;2(11):1578\u20139.","journal-title":"EBioMedicine"},{"issue":"16","key":"367_CR27","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s40265-018-1001-8","volume":"78","author":"MS Eapen","year":"2018","unstructured":"Eapen MS, Hansbro PM, Larsson-Callerfelt AK, et al. Chronic obstructive pulmonary disease and lung cancer: underlying pathophysiology and new therapeutic modalities. Drugs. 2018;78(16):1717\u201340.","journal-title":"Drugs"},{"issue":"1","key":"367_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1755-7682-5-2","volume":"5","author":"F Imtiaz","year":"2012","unstructured":"Imtiaz F, Shafique K, Mirza SS, et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 2012;5(1):2.","journal-title":"Int Arch Med"},{"issue":"3","key":"367_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2025.152903","volume":"230","author":"D Li","year":"2025","unstructured":"Li D, Liu L, Lv J, Xiong X. The clinical significance of peripheral blood-related inflammatory markers in patients with AECOPD. Immunobiology. 2025;230(3):152903.","journal-title":"Immunobiology"},{"issue":"2","key":"367_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/thoraxjnl-2020-215167","volume":"76","author":"B David","year":"2021","unstructured":"David B, Bafadhel M, Koenderman L, De Soyza A. Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait. Thorax. 2021;76(2):188\u201395.","journal-title":"Thorax"},{"key":"367_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13216339","author":"LK Appleton","year":"2024","unstructured":"Appleton LK, Hanania NA, Adrish M. Personalized COPD care: the future of precision-based therapies. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13216339.","journal-title":"J Clin Med"},{"issue":"1","key":"367_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.chest.2019.02.406","volume":"156","author":"MI MacDonald","year":"2019","unstructured":"MacDonald MI, Osadnik CR, Bulfin L, et al. Low and high blood eosinophil counts as biomarkers in hospitalized acute exacerbations of COPD. Chest. 2019;156(1):92\u2013100.","journal-title":"Chest"},{"key":"367_CR33","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0022-2018","author":"VK Sidhaye","year":"2018","unstructured":"Sidhaye VK, Nishida K, Martinez FJ. Precision medicine in COPD: where are we and where do we need to go? Eur Respir Rev. 2018. https:\/\/doi.org\/10.1183\/16000617.0022-2018.","journal-title":"Eur Respir Rev"},{"issue":"5","key":"367_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/arm91050031","volume":"91","author":"S Dragonieri","year":"2023","unstructured":"Dragonieri S, Bikov A, Capuano A, Scarlata S, Carpagnano GE. Methodological aspects of induced sputum. Adv Respir Med. 2023;91(5):397\u2013406.","journal-title":"Adv Respir Med"},{"key":"367_CR35","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00686-2023","author":"A Higham","year":"2023","unstructured":"Higham A, Beech A, Dean J, Singh D. Exhaled nitric oxide, eosinophils and current smoking in COPD patients. ERJ Open Res. 2023. https:\/\/doi.org\/10.1183\/23120541.00686-2023.","journal-title":"ERJ Open Res"},{"issue":"1","key":"367_CR36","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jaci.2017.07.039","volume":"141","author":"CH Martinez","year":"2018","unstructured":"Martinez CH, Li SX, Hirzel AJ, et al. Alveolar eosinophilia in current smokers with chronic obstructive pulmonary disease in the SPIROMICS cohort. J Allergy Clin Immunol. 2018;141(1):429\u201332.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"367_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1183\/09031936.00.15110900","volume":"15","author":"SR Rutgers","year":"2000","unstructured":"Rutgers SR, Timens W, Kaufmann HF, et al. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J. 2000;15(1):109\u201315.","journal-title":"Eur Respir J"},{"issue":"5","key":"367_CR38","first-page":"368","volume":"12","author":"WB LeMaster","year":"2025","unstructured":"LeMaster WB, Ingersoll SA, Phee H, et al. Diagnosing Type 2 Inflammation in COPD: comparison of blood and sputum eosinophil assessment in the university of California Los Angeles COPD phenotyping study. Chronic Obstr Pulm Dis. 2025;12(5):368\u201379.","journal-title":"Chronic Obstr Pulm Dis"},{"key":"367_CR39","first-page":"327","volume":"5","author":"Y Wen","year":"2010","unstructured":"Wen Y, Reid DW, Zhang D, et al. Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD. Int J Chron Obstruct Pulmon Dis. 2010;5:327\u201334.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"8","key":"367_CR40","volume":"14","author":"A Hassan","year":"2022","unstructured":"Hassan A, Jabbar N. C-reactive protein as a predictor of severity in chronic obstructive pulmonary disease: an experience from a tertiary care hospital. Cureus. 2022;14(8):e28229.","journal-title":"Cureus"},{"issue":"8","key":"367_CR41","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.rmed.2007.03.005","volume":"101","author":"R Tkacova","year":"2007","unstructured":"Tkacova R, Kluchova Z, Joppa P, Petrasova D, Molcanyiova A. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD. Respir Med. 2007;101(8):1670\u20136.","journal-title":"Respir Med"},{"issue":"6","key":"367_CR42","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1164\/rccm.200602-243OC","volume":"174","author":"D Aronson","year":"2006","unstructured":"Aronson D, Roterman I, Yigla M, et al. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am J Respir Crit Care Med. 2006;174(6):626\u201332.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"367_CR43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1042\/CS20070382","volume":"115","author":"A Valipour","year":"2008","unstructured":"Valipour A, Schreder M, Wolzt M, et al. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Clin Sci (Lond). 2008;115(7):225\u201332.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"367_CR44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.archger.2010.10.015","volume":"53","author":"A Corsonello","year":"2011","unstructured":"Corsonello A, Pedone C, Battaglia S, et al. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD). Arch Gerontol Geriatr. 2011;53(2):190\u20135.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"367_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1024\/0040-5930.63.1.108","volume":"63","author":"WH Reinhart","year":"2006","unstructured":"Reinhart WH. Erythrocyte sedimentation rate--more than an old fashion? Ther Umsch. 2006;63(1):108\u201312.","journal-title":"Ther Umsch"},{"issue":"4","key":"367_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5507\/bp.2020.056","volume":"164","author":"J Zatloukal","year":"2020","unstructured":"Zatloukal J, Brat K, Neumannova K, et al. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020;164(4):325\u201356.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"367_CR47","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.2147\/COPD.S175706","volume":"14","author":"FM Franssen","year":"2019","unstructured":"Franssen FM, Alter P, Bar N, et al. Personalized medicine for patients with COPD: where are we? Int J Chron Obstruct Pulmon Dis. 2019;14:1465\u201384.","journal-title":"Int J Chron Obstruct Pulmon Dis"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-026-00367-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-026-00367-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-026-00367-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:24:52Z","timestamp":1782141892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-026-00367-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["367"],"URL":"https:\/\/doi.org\/10.1007\/s41030-026-00367-w","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"5 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Associate Professor Sohal reports honorarium for lectures from Chiesi, travel support from Chiesi, AstraZeneca, Boehringer Ingelheim, and GSK, and research grants from Boehringer Ingelheim and Lung Therapeutics, outside the submitted work; and has served on the Small Airway Advisory Board for Chiesi Australia for which an honorarium has been received. Associate Professor Sohal has served as Chair for the Chiesi Advisory Board for Centre of Excellence in Oscillometry, for which an honorarium was received. Associate Professor Sukhwinder Sohal (senior author on this paper) is on the Editorial Board of\n                      Pulmonary Therapy\n                      and was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Dr Wenying Lu, Dr Maddison Waters, Dr Josie Larby, Dr Sapha Shibeeb, Professor Steven Bozinovski, Professor Stavros Selemidis, Professor Jonathan McQualter, Professor Ross Vlahos, Professor Md Imtaiyaz Hassan, and Associate Professor Heinrich Weber do not have any conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Human Research Ethics Committee (Tasmania) (Ethics: H0013051).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent Statement"}}]}}